Filing Details
- Accession Number:
- 0000950170-25-085490
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-12 16:37:21
- Reporting Period:
- 2025-06-10
- Filing Date:
- 2025-06-12
- Accepted Time:
- 2025-06-12 16:37:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1815776 | Lenz Therapeutics Inc. | LENZ | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1687880 | Versant Venture Capital Vi, L.p. | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1750266 | Versant Venture Capital Vii, L.p. | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1777652 | Versant Ventures Vi Gp-Gp, Llc | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1777654 | Versant Ventures Vi Gp, L.p. | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1777655 | Versant Ventures Vii Gp, L.p. | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1777656 | Versant Ventures Vii Gp-Gp, Llc | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1832235 | Versant Vantage Ii, L.p. | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1839789 | Versant Vantage Ii Gp-Gp, Llc | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No | |
1839790 | Versant Vantage Ii Gp, L.p. | One Sansome Street, Suite 1650 San Francisco CA 94104 | No | No | No | No |
Transaction Summary
Sold: | 350,000 shares | Avg. Price: $29.00 | Total Value: $10,150,000.00 |
Number of Shares After Transactions: | 1,248,789 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-06-10 | 350,000 | $29.00 | 1,248,789 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,101,199 | Direct | |
Common Stock | 842,162 | Indirect | See footnote |
Footnotes
- These shares are held by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP-GP, LLC ("VV VII GP") is the sole general partner of Versant Ventures VII GP, L.P. ("VV VII") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
- These shares are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
- These shares are held by Versant Vantage II, L.P. ("VV II"). Versant Vantage II GP-GP, LLC ("VV II GP-GP") is the sole general partner of Versant Vantage II GP, L.P. ("VV II GP") and VV II GP is the sole general partner of VV II. Each of VV II GP-GP and VV II GP may be deemed to share voting, investment and dispositive power over the shares held by VV II and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.